Drug Shortage Report for BOOSTRIX-POLIO
| Report ID | 19888 |
| Drug Identification Number | 02312557 |
| Brand name | BOOSTRIX-POLIO |
| Common or Proper name | Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INACTIVATED POLIOVIRUS TYPE I INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE III TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED PERTUSSIS TOXOID ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTACTIN ADSORBED |
| Strength(s) | 40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 10's |
| ATC code | J07CA |
| ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-11-08 |
| Estimated end date | 2017-12-07 |
| Actual end date | 2017-12-06 |
| Shortage status | Resolved |
| Updated date | 2017-12-07 |
| Company comments | Supply released November 10, 2017 with limited quantity. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.